A Phase 2 Study in Patients with Pancreatic Cancer

Update Il y a 4 ans
Reference: EUCTR2011-003822-29

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To determine if LY2495655 administered in combination with chemotherapy improves overall survival (OS), compared to chemotherapy in combination with placebo in patients with Stage II-IV unresectable pancreatic cancer


Inclusion criteria

  • Muscle wasting and weakness associated with cancer of the pancreas that is locally advanced or metastatic